Related references
Note: Only part of the references are listed.Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi
Michele Merli et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
A three-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma
Enrico Derenzini et al.
HAEMATOLOGICA (2021)
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi
Francesco Merli et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
EASL recommendations on treatment of hepatitis C: Final update of the series
Jean-Michel Pawlotsky et al.
JOURNAL OF HEPATOLOGY (2020)
Concomitant therapy with direct-acting antivirals and chemoimmunotherapy in HCV-associated diffuse large B-cell lymphoma
Vincenzo Occhipinti et al.
DIGESTIVE AND LIVER DISEASE (2019)
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas
Michele Merli et al.
ONCOLOGIST (2019)
Efficacy and safety of new direct antiviral agents in hepatitis C virus-infected patients with diffuse large B-cell non-Hodgkin's lymphoma
Marcello Persico et al.
HEPATOLOGY (2018)
Biased IGH VDJ gene repertoire and clonal expansions in B cells of chronically hepatitis C virus-infected individuals
Felicia A. Tucci et al.
BLOOD (2018)
From hepatitis C virus infection to B-cell lymphoma
L. Couronne et al.
ANNALS OF ONCOLOGY (2018)
Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations
Carlo Visco et al.
BRITISH JOURNAL OF CANCER (2017)
Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders
B. Dai et al.
ONCOGENE (2016)
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection
Luca Arcaini et al.
BLOOD (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection
Luca Arcaini et al.
HAEMATOLOGICA (2015)
Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)
Alessandra Tucci et al.
LEUKEMIA & LYMPHOMA (2015)
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi
Michele Merli et al.
HAEMATOLOGICA (2014)
Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: a clinicopathological study
Manuela Mollejo et al.
MODERN PATHOLOGY (2014)
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development
Davide Rossi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma
Davide Rossi et al.
BLOOD (2011)
The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age
Sylvain Mareschal et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma
P. Ruminy et al.
LEUKEMIA (2011)
Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis
Daisuke Ennishi et al.
BLOOD (2010)
Hepatitis C virus-associated B-cell proliferation - the role of serum B lymphocyte stimulator (BLyS/BAFF)
D. Sene et al.
RHEUMATOLOGY (2007)
Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy
C. Visco et al.
ANNALS OF ONCOLOGY (2006)
Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells
K Machida et al.
JOURNAL OF VIROLOGY (2005)
Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma:: A multicenter Italian experience
D Vallisa et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study
A Mele et al.
BLOOD (2003)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
